Le Lézard
Classified in: Health
Subject: AWD

National Cancer Institute Designates Jefferson's Sidney Kimmel Cancer Center as a Comprehensive Cancer Center

As part of the Sidney Kimmel Cancer Center Research Consortium, Thomas Jefferson University and Drexel University have partnered to transform breakthrough research into life-changing cancer treatments 

PHILADELPHIA, April 18, 2024 /PRNewswire/ -- Today, Jefferson announced that its Sidney Kimmel Cancer Center (SKCC) has earned a National Cancer Institute (NCI) "Comprehensive" Cancer Center designation, the highest recognition awarded by the NCI. 

This recognition places SKCC among an elite group of 57 cancer centers nationwide, providing exceptional cancer care.

This recognition places SKCC among an elite group of only 57 cancer centers nationwide, providing exceptional and personalized cancer care and superior outcomes, fueled by a robust clinical research program. 

"We at Jefferson have always known that the Sidney Kimmel Cancer Center is among the best of the best. Now it's official, with an important new designation that's shared with less than two percent of the nation's cancer centers," said Joseph G. Cacchione, MD, CEO, Jefferson. "I couldn't be prouder of the Sidney Kimmel Cancer Center team, and now our patients will be treated at one of just 57 elite cancer centers in the country with this notable distinction."

This designation is a testament to Jefferson's work to save lives by developing, testing, and applying innovative approaches to improve cancer clinical outcomes. The Sidney Kimmel Cancer Center has been recognized for its leadership and resources, in addition to demonstrating an added depth and breadth of basic science, clinical research, and population science.

The prestigious NCI Comprehensive Cancer Center designation is granted competitively to institutions characterized by the highest level of scientific excellence in cancer research and the ability to translate scientific discoveries into novel treatments. NCI Comprehensive Cancer Centers are also responsible for educating the public, training future healthcare professionals, and providing outreach to underserved populations. Comprehensive cancer centers address the cancer burden unique to the communities they serve through tailored research programs and community outreach.

"Many people have been responsible for the success of the cancer center to this day. The Sidney Kimmel Cancer Center's staff has worked tirelessly for years to make the comprehensive status a reality. We are the heart and soul of cancer care in Philadelphia and the communities we serve, and while this is an immense honor, it is also a tremendous responsibility. Comprehensiveness translates our commitment to cancer prevention, expertise, and leadership in delivering uncompromising care and breakthrough cancer research until every cancer is cured. We celebrate this milestone with our clinicians, support staff, patients, and their loved ones." said Andrew Chapman, DO, FACP, EVP Cancer Research and Oncology Services, and Director, Sidney Kimmel Cancer Center, Jefferson Health.

As the federal government's principal cancer research and training agency, the NCI awards designations based on excellence in cancer treatment, diagnosis, and prevention. Jefferson received an initial NCI Designation in 1996. 

"The NCI Comprehensive designation is an important milestone in our commitment to reducing the cancer burden not only in Philadelphia, but across the United States and globally," said Dr. Susan C. Aldridge, Interim President, Thomas Jefferson University. "It is the culmination of Jefferson's continued dedication to research, education and patient care. As partners in the Sidney Kimmel Cancer Center Research Consortium, Jefferson, along with Drexel University, is focused on transforming breakthrough research into life-changing cancer treatment.

Every five years, a peer review process occurs to assess the extent to which the center has promoted or is likely to promote excellence in research that may reduce the incidence, morbidity, and mortality attributable to cancer among persons within its service area and beyond. Reviewers evaluate how well the center's leadership, organization, and processes for development and evaluation facilitate scientific productivity, strengthen the institution's research capabilities, and enable its investigators to take advantage of scientific opportunities beyond what would have likely occurred at the institution without the Cancer Center Support Grants (CCSGs.) These grants predominantly support the research mission of the center. 

"This prestigious designation recognizes our Center's excellence in cancer prevention, patient care and clinical research. It also elevates our entire health system's capabilities to deliver cutting-edge care and innovative solutions to our patients right here in our community," added Baligh R. Yehia, MD, MPP, MSc, FACP, President, Jefferson Health.

Serving more than 8,900 patients annually, the matrixed consortium cancer center provides the most advanced, research-based care by building upon the unique expertise, resources and capabilities of two highly regarded Philadelphia-based institutions, Thomas Jefferson University and Drexel University.

"Drexel University and Thomas Jefferson University share a research-driven mission to make an impact In the Philadelphia region and beyond. The partnership between our storied institutions allows us to optimize our respective research strengths and focus on the specific needs of the diverse communities across Southeastern Pennsylvania and South Jersey," said John A. Fry, President, Drexel University. "This designation is a great win for the region, as it will strengthen the impact of scientific discovery across the consortium."

The Sidney Kimmel Cancer Center offers advanced treatment plans, access to a wide breadth of clinical trials, and comprehensive supportive services for patients throughout the region via its advanced care hubs in Philadelphia, South Jersey, and Montgomery and Bucks counties. Patients can access local resources, backed by the NCI-designated academic medical center in Center City Philadelphia.

Enhancing the Patient Experience

Oncology patients will receive cancer care at the Honickman Center, Jefferson's new state-of-the-art outpatient care center, which opened its doors to patients on April 15. The Sidney Kimmel Cancer Center is on the 12th, 14th and 15th floors, where patients will be surrounded by a calming environment with open sunlit spaces and a breathtaking view of the Philadelphia skyline. Fifty-eight infusion chairs offering privacy, recliners with massage features, comfortable spaces for family members, and carefully selected artwork in key areas are all part of the healing experience and patient-centric care.

Generous Gift

In recognition of this prestigious NCI designation, philanthropists Caroline and Sidney Kimmel will generously match every dollar raised for the Sidney Kimmel Cancer Center Innovation Fund, up to $250,000, as part of Jefferson's annual Giving Day. Mr. and Mrs. Kimmel have been extremely generous benefactors to Jefferson, having given more than $200 million over the years including: providing cornerstone funding to establish the Sidney Kimmel Cancer Center in 1995, as well as transformational support for research into the prevention of cardiovascular disease, and Jefferson's largest-ever gift of $110 million to name the Sidney Kimmel Medical College at Thomas Jefferson University in 2014. With this latest NCI comprehensiveness designation, the Kimmels are the only family to have two comprehensive cancer centers in the country named after them.

About Jefferson
Nationally ranked, Jefferson, which is principally located in the greater Philadelphia region and southern New Jersey, is reimagining health care and higher education to create unparalleled value. Jefferson is more than 42,000 people strong, dedicated to providing the highest-quality, compassionate clinical care for patients; making our communities healthier and stronger; preparing tomorrow's professional leaders for 21st-century careers; and creating new knowledge through basic/programmatic, clinical and applied research. Thomas Jefferson University, home of Sidney Kimmel Medical College, Jefferson College of Nursing, and the Kanbar College of Design, Engineering and Commerce, dates back to 1824 and today comprises 10 colleges and three schools offering 200+ undergraduate and graduate programs to more than 8,300 students. Jefferson Health, nationally ranked as one of the top healthcare systems in the country and the largest provider in the Philadelphia area, serves patients through millions of encounters each year at 17 hospitals and more than 160 outpatient and urgent care locations throughout the region. Jefferson Health Plans is a not-for-profit managed health care organization providing a broad range of health coverage options in Pennsylvania and New Jersey for more than 35 years.

SOURCE Jefferson

These press releases may also interest you

at 16:30
Sienna Senior Living Inc. ("Sienna" or the "Company") is pleased to announce that it has received shareholder approval in respect of all resolutions to be voted upon at its annual and special meeting of shareholders held on May 29, 2024 (the...

at 16:15
Bruker Corporation ("Bruker" or the "Company") today announced the launch of an underwritten registered public offering of 6,000,000 shares of its common stock. In addition, Bruker expects to grant the underwriters a 30-day option to purchase up to...

at 16:15
CareRx Corporation ("CareRx" or the "Company") , Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that as part of the Company's commitment to Board refreshment and to realign...

at 16:15
Jazz Pharmaceuticals plc today announced that Company management will participate in the following investor conferences: Jefferies Global Healthcare Conference on Thursday, June 6, 2024 Fireside chat at 11:00 a.m. PT / 2:00 p.m. ET / 7:00 p.m....

at 16:10
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced today that David Hung, M.D., Founder,...

at 16:10
Vir Biotechnology, Inc. today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, at 11:00...

News published on and distributed by: